Augmedix Inc
NASDAQ:AUGX
Augmedix Inc
NASDAQ:AUGX
Price:
2.85 USD
0.35%
Market Closed
Updated:
Apr 25, 2024
Augmedix Inc
Net Income (Common)
Last
Value
3-Years CAGR
5-Years CAGR
|
Augmedix Inc
Net Income (Common) Peer Comparison
Comparables:
VEEV
INSP
EVH
DOCS
GDRX
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Augmedix Inc
NASDAQ:AUGX
|
Net Income (Common)
-$19.2m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Net Income (Common)
$525.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
18%
|
CAGR 10-Years
48%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Net Income (Common)
-$21.2m
|
CAGR 3-Years
28%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Evolent Health Inc
NYSE:EVH
|
Net Income (Common)
-$142.3m
|
CAGR 3-Years
25%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Net Income (Common)
$112.8m
|
CAGR 3-Years
119%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Net Income (Common)
-$8.9m
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Augmedix Inc's Net Income (Common)?
Net Income (Common)
-19.2m
USD
-19.2m
USD
Based on the financial report for Dec 31, 2023, Augmedix Inc's Net Income (Common) amounts to -19.2m USD.
What is Augmedix Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
5%
5%
Over the last year, the Net Income (Common) growth was 22%. The average annual Net Income (Common) growth rates for Augmedix Inc have been -7% over the past three years , 5% over the past five years .
You don't have any saved screeners yet
